These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8623428)

  • 1. Role of humoral immunity in pancreatic islet allo- and xenograft rejection.
    Ahn M; Sohn C; Chang E; Chu G; DeMatteo RP; Barker CF; Markmann JF
    Transplant Proc; 1996 Apr; 28(2):840-1. PubMed ID: 8623428
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged survival of class I deficient mouse islet allografts but not xenografts.
    Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF
    Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
    Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
    Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenogeneic but not allogeneic pancreatic islet graft survival in recipients lacking humoral immunity and major histocompatibility complex class II antigens.
    Chu G; Markmann JF; Ahn M; Chang E; DeMatteo RP; Ketchum RJ; Brayman KI; Deng S; Barker CF
    Transplant Proc; 1997; 29(1-2):901-2. PubMed ID: 9123579
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
    Desai NM; Bassiri H; Odorico JS; Koller BH; Smithies O; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1993 Feb; 25(1 Pt 2):961-2. PubMed ID: 8442280
    [No Abstract]   [Full Text] [Related]  

  • 7. CD4+ T cells are both necessary and sufficient for islet xenograft rejection.
    Gill RG; Wolf L; Daniel D; Coulombe M
    Transplant Proc; 1994 Jun; 26(3):1203. PubMed ID: 7913259
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of adhesion molecules in islet allo- and xenograft rejection.
    Gotoh M; Ohzato H; Fukuzaki T; Ohta Y; Nishihara M; Hasuike Y; Umeshita K; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M
    Transplant Proc; 1996 Apr; 28(2):617. PubMed ID: 8623304
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M; Laufer TM; Auchincloss H; Smith RN
    Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular requirements for pancreatic islet xenograft rejection.
    Ahn M; Chang E; Chu G; Barker CF; Markmann JF
    Transplant Proc; 1995 Dec; 27(6):3302-3. PubMed ID: 8539963
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides.
    Zeng Y; Torres M; Wang Y; Montag A; Thistlethwaite JR
    Transplant Proc; 1995 Feb; 27(1):176-7. PubMed ID: 7878961
    [No Abstract]   [Full Text] [Related]  

  • 12. Extended and expanded studies of xenograft rejection in immunodeficient animals.
    Thomas F; Araneda D; Henretta J; Pittman K; Marchman W
    Transplant Proc; 1994 Jun; 26(3):1224-7. PubMed ID: 8029895
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts.
    Campos L; Deli BC; Kern JH; Kim JI; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1995 Feb; 27(1):254-5. PubMed ID: 7878991
    [No Abstract]   [Full Text] [Related]  

  • 14. Organ-specific natural antibodies in pig islet xenotransplantation.
    Braun K; Jahr H
    Transplant Proc; 1992 Dec; 24(6):2979. PubMed ID: 1466021
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of donor MHC compatibility in the allo- and autoimmune destruction of islet grafts in the BB rat.
    Stegall MD; Chabot JA; Tezuka K; Reemtsma K; Hardy MA
    Transplant Proc; 1990 Apr; 22(2):844. PubMed ID: 2109414
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoisolative effectiveness and limitation of agarose in a bioartificial pancreas.
    Iwata H; Takagi T; Kobayashi K; Yang H; Ito F
    Transplant Proc; 1994 Apr; 26(2):789. PubMed ID: 8171663
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
    Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of direct and indirect antigen presentation in the response to islet xenografts.
    Gill RG
    Transplant Proc; 1992 Apr; 24(2):642-3. PubMed ID: 1533075
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of MHC class I or II "knock out" mice to delineate the role of these molecules in acceptance/rejection of xenografts.
    Sun H; Wakizaka Y; Rao AS; Pan F; Madariaga J; Park IY; Celli S; Fung JJ; Starzl TE; Valdivia LA
    Transplant Proc; 1996 Apr; 28(2):732. PubMed ID: 8623370
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenic properties of fetal mouse proislets.
    Simeonovic CJ; Lafferty KJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):938-9. PubMed ID: 3152643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.